Integrated Approaches and Practical Recommendations in Patient Care Identified with 5q Spinal Muscular Atrophy...

Area of Science:

• Neurology
• Genetics
• Public Health

Background:

• 5q Spinal Muscular Atrophy (SMA) is a severe genetic neuromuscular disorder characterized by motor neuron degeneration.
• Early diagnosis and intervention significantly improve clinical outcomes and patient prognosis.
• Current therapeutic advancements highlight the critical need for widespread newborn screening programs.

Purpose of the Study:

• To address key considerations for integrating 5q-SMA screening into Brazil's National Newborn Screening Program.
• To explore Brazil's specific challenges and opportunities in implementing a national SMA screening initiative.
• To guide healthcare professionals and policymakers in establishing effective SMA care pathways.

Main Methods:

• Review of current 5q-SMA diagnostic and therapeutic strategies.
• Analysis of logistical and clinical factors for newborn screening implementation in Brazil.
• Examination of genetic testing, patient referral timelines, and treatment algorithm considerations.

Main Results:

• Early detection through newborn screening is crucial for timely intervention in 5q-SMA.
• Brazil faces unique challenges in program implementation, including genetic testing access and referral networks.
• Standardized protocols for screening, referral, and treatment are essential for program success.

Conclusions:

• Implementing a national 5q-SMA newborn screening program in Brazil is feasible and necessary.
• Addressing logistical and healthcare system challenges is critical for effective program execution.
• This initiative aims to improve care for Brazilian newborns diagnosed with 5q-SMA and foster regional collaboration.